( 02616.hk)
市盈率-15.21市净率10.78股息率0%上市时间2019-02-26股价4.62港币涨跌幅-5.33%成交金额1,336.13万港币换手率0.18%市值73.95亿港币H股市值73.95亿港币总股本16.01亿H股本16.01亿每手股数500上市至今年化投资收益率-12.87%港股通持仓占H股比例5.08% (3.86亿港币2026-07-22) 累计做空占H股比例4.92% (3.57亿港币2026-07-17)
所属三级行业生物技术 (恒生) 市盈率122.29市净率4.46股息率0.37%恒生:医疗保健业药品及生物科技生物技术
备注 (3): 双击编辑备注
发表讨论

基石药业-B(02616) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1楊建新Executive DirectorCEO2022-08-25--
2HITCHNER III Walton KennethNon Executive Director2021-12-10--
3胡正國Non Executive Director2021-07-09--
4林向紅Non Executive Director2020-11-30--
5曹彥凌Non Executive Director2019-05-152023-01-18
6CHEW Herbert PaulIndependent Non Executive Director2019-02-14--
7孫洪斌Independent Non Executive Director2019-02-14--
8胡定旭Independent Non Executive Director2019-02-14--
9陳連勇Non Executive Director2018-08-142021-07-09
10張國斌Non Executive Director2018-05-082020-11-30
11童小幪Non Executive Director2018-02-282019-05-15
12JIANG Ning Jun FrankExecutive Director2016-11-032022-08-25
13趙群Non Executive Director2016-04-012021-12-10
14李偉Non Executive DirectorChairman2015-12-02--